NHS England Offers Vertex Final Orkambi Deal

The increasingly public row between Vertex and NHS England continues as NHS England claims it has offered Vertex the “largest ever financial commitment of its type” in its 70-year history. Meanwhile, Vertex has revealed that the NHS has offered a price that is significantly lower than the list price.

Cystic fibrosis word cloud
NHS England And Vertex Clash Over Drug Pricing • Source: Shutterstock

The National Health Service in England has set out what it says is its “final” offer to enable patients in England to access Vertex’s cystic fibrosis drugs, including Orkambi (lumacaftor/ivacaftor). The amount offered by NHS England would represent the biggest financial commitment in its history.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on Pink Sheet for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required

More from Europe

More from Geography